Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT02502188 · TERMINATED
Trial details
- NCT number
- NCT02502188
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-17
- Primary completion
- 2015-11-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.